FDA Updates Safety Warning on Hintermann Series H3 Total Ankle Replacement: Patients Face Higher Risk of Failure and Revision Surgery

FDA Updates Safety Warning on Hintermann Series H3 Total Ankle Replacement: Patients Face Higher Risk of Failure and Revision Surgery

The U.S. Food and Drug Administration (FDA) issued an updated safety communication regarding the Hintermann Series H3 Total Ankle Replacement (TAR) system. The FDA Hintermann notice warns patients face a higher-than-expected risk of device failure, revision surgery, and polyethylene component fractures. The Agency recommends surgeons and patients consider other treatment options when possible. (U.S. Food and Drug Administration)

For patients who have experienced pain, loosening, instability, or required additional ankle surgery after receiving a Hintermann H3 implant, the FDA’s latest findings raise serious questions about the long-term safety and durability of the device. (U.S. Food and Drug Administration)

What Is the Hintermann Series H3 Total Ankle Replacement?

The Hintermann Series H3 Total Ankle Replacement is a mobile-bearing ankle implant approved by the FDA in 2019 for patients suffering from painful ankle arthritis caused by:

• Osteoarthritis
• Post-traumatic arthritis
• Inflammatory arthritis

The system consists of metal tibial and talar components and a polyethylene (plastic) bearing insert designed to allow motion within the ankle joint. (Vilex)

Why Did the FDA Issue This Safety Warning?

The FDA first warned patients and doctors in February 2024 after post-approval study data showed significantly higher failure rates than were observed before the device was approved. (U.S. Food and Drug Administration)

In its June 2026 update, the FDA strengthened its warning after reviewing:

• Post-market study results
• Medical literature
• Registry data
• Adverse event reports
• Manufacturer-provided information

The agency concluded that the H3 system presents an elevated long-term risk of failure and revision surgery compared to other available ankle replacement devices. (U.S. Food and Drug Administration)

Key FDA Findings

The FDA highlighted several concerning findings:

Nearly Double the Revision Risk

Registry data reviewed by the FDA found that patients with the Hintermann H3 experienced a statistically significant increase in revision surgery compared to recipients of other ankle replacement devices.

The FDA reported a hazard ratio of 1.93, meaning H3 patients faced nearly twice the risk of revision surgery compared with patients implanted with competing ankle replacement systems. (U.S. Food and Drug Administration)

Polyethylene Fractures Occur More Frequently

The agency also found that fractures of the polyethylene bearing insert occurred at approximately four times the rate seen with other total ankle replacement devices. Polyethylene breakage became one of the leading reasons patients required revision surgery. (U.S. Food and Drug Administration)

Common Reasons for Revision Surgery

According to the FDA, the most frequent reasons for revision procedures involving the H3 system included:

• Implant loosening
• Polyethylene breakage
• Infection
• Instability
• Persistent pain
• Bone loss (lysis)

These complications can result in additional surgeries, prolonged recovery, and worsening ankle function. (U.S. Food and Drug Administration)

Symptoms of a Failing Hintermann H3 Ankle Replacement

Patients who have received a Hintermann H3 implant should contact their orthopedic surgeon if they experience:

• New or worsening ankle pain
• Swelling around the ankle
• Difficulty walking
• Inability to bear weight
• Instability
• Grinding, clicking, or unusual noises
• Reduced range of motion
• Weakness around the implant

The FDA notes that physicians may order X-rays or CT scans to evaluate whether the implant has loosened or whether the polyethylene component has fractured. (U.S. Food and Drug Administration)

What Should Patients Do?

The FDA does not recommend preventive removal of a properly functioning implant. In other words, just because you have one does not mean you should go run out and try to get it removed. Speak with your healthcare provider. Patients should:

1. Monitor for new symptoms.
2. Attend follow-up appointments.
3. Discuss alternative treatment options if additional surgery becomes necessary.
4. Report complications to the FDA’s MedWatch program.

Patients considering ankle replacement surgery should discuss all available options, including ankle fusion and alternative ankle replacement devices. The FDA specifically advises consideration of other treatment options where possible. (U.S. Food and Drug Administration)

Potential Legal Claims Involving the Hintermann H3

Medical device manufacturers are required to design reasonably safe products and adequately warn physicians and patients about known risks.

When a medical device demonstrates higher-than-expected failure rates after approval, injured patients often investigate whether:

• The device was defectively designed.
• The manufacturer knew or should have known of elevated risks.
• Warnings provided to surgeons and patients were adequate.
• Post-market safety concerns were properly reported.

Individuals who required revision surgery, experienced implant failure, or suffered complications related to a Hintermann H3 ankle replacement may wish to explore their legal options.

What Causes Ankle Revision Surgery?

What Conditions and Symptoms May Indicate a Failed Hintermann H3 Total Ankle Replacement

How do I know if my Hintermann H3 ankle replacement is failing?

A failed ankle replacement often causes new or worsening symptoms after an initial period of improvement. Common warning signs include persistent ankle pain, swelling, instability, difficulty walking, stiffness, reduced range of motion, and an inability to bear weight comfortably.

Patients experiencing these symptoms should seek prompt evaluation from an orthopedic surgeon.

Can ankle pain indicate a failed Hintermann H3 implant?

Yes. Chronic or worsening ankle pain is one of the most common signs of implant failure.

Pain may occur because of:

• Implant loosening
• Polyethylene bearing fracture
• Bone loss around the implant
• Instability
• Implant malalignment
• Infection

Many patients report pain during walking, climbing stairs, or standing for extended periods.

What is implant loosening?

Implant loosening occurs when the metal components of the ankle replacement lose their attachment to the surrounding bone.

Symptoms may include:

• Deep ankle pain
• A feeling that the ankle is shifting or moving
• Difficulty bearing weight
• Progressive loss of function

Loosening is one of the leading causes of revision surgery after total ankle replacement.

What is polyethylene fracture?

The Hintermann H3 contains a polyethylene (plastic) bearing that allows movement between the metal components.

The FDA has specifically identified polyethylene fractures as occurring at a significantly higher rate in the Hintermann H3 than in many other ankle replacement systems.

A fractured polyethylene insert may cause:

• Sudden pain
• Clicking or grinding sensations
• Instability
• Locking of the ankle joint
• Difficulty walking

In many cases, revision surgery is required.

Why does my ankle click, pop, or grind after ankle replacement surgery?

Mechanical noises may indicate:

• Polyethylene wear or fracture
• Implant loosening
• Misalignment of implant components
• Joint instability

While occasional clicking may not always indicate a serious problem, new or worsening mechanical symptoms should be evaluated by a physician.

Can a failed ankle replacement cause instability?

Yes. Many patients describe feeling as though:

• The ankle “gives out”
• The ankle shifts unexpectedly
• They cannot trust the ankle while walking
• They are at increased risk of falling

Instability can result from implant loosening, component wear, ligament problems, or failure of the implant itself.

What is osteolysis and why is it dangerous?

Osteolysis is the loss of bone surrounding an implant.

It can occur when wear particles from the implant trigger an inflammatory reaction that gradually destroys bone tissue.

Symptoms may include:

• Increasing pain
• Weakness
• Implant loosening
• Fractures around the implant

Severe osteolysis can make revision surgery more difficult and may require bone grafting procedures.

Can a failed Hintermann H3 cause difficulty walking?

Absolutely.

Many patients with a failing ankle replacement report:

• Limping
• Reduced walking distance
• Trouble climbing stairs
• Difficulty standing for long periods
• Loss of mobility

These functional limitations often worsen as implant failure progresses.

Can a failed ankle replacement cause arthritis in nearby joints?

Yes. When an ankle implant fails or loses proper alignment, abnormal forces can be transferred to surrounding joints in the foot and hindfoot. This can contribute to:

• Subtalar arthritis
• Midfoot arthritis
• Progressive pain
• Reduced mobility

Can infection cause ankle replacement failure?

Yes. Although less common than loosening or mechanical failure, infection is one of the most serious complications associated with joint replacement devices. Symptoms may include:

• Persistent swelling
• Redness
• Warmth around the ankle
• Drainage from the surgical site
• Fever
• Increasing pain

Infections often require additional surgery and prolonged antibiotic treatment.

Can a failed ankle replacement lead to permanent disability?

Unfortunately, yes. Some patients experience:

• Chronic pain
• Permanent loss of motion
• Difficulty walking
• Need for multiple revision surgeries
• Conversion to ankle fusion
• Long-term mobility limitations

The severity of disability often depends on the extent of bone loss, implant damage, and how quickly the failure is identified and treated.

What tests can diagnose a failed Hintermann H3 ankle replacement?

Doctors may use several diagnostic tools, including:

• X-rays
• CT scans
• MRI studies (when appropriate)
• Bone scans
• Blood tests to evaluate infection
• Physical examination

These studies can help identify loosening, fractures, wear, bone loss, infection, and other complications.

What should I do if I think my Hintermann H3 ankle replacement has failed?

You should promptly contact your orthopedic surgeon if you experience:

• New or worsening pain
• Swelling
• Instability
• Difficulty walking
• Clicking, grinding, or popping sensations
• Loss of ankle function

Early diagnosis may help prevent further damage and improve treatment options.

Related Potential Questions or Queries that May Lead you to Discovery You have a Failed Hintermann H3

• Why does my ankle replacement hurt?
• Signs of a failed ankle replacement
• Ankle implant loosening symptoms
• Clicking after ankle replacement surgery
• Swollen ankle years after replacement
• Failed ankle replacement revision surgery
• Polyethylene fracture ankle implant
• Why is my ankle replacement unstable?
• Pain years after ankle replacement
• Can an ankle replacement wear out?

Potential Questions about the FDA Hintermann H3 Safety Notice

What is the FDA warning about the Hintermann H3 ankle replacement?

The FDA warns that the Hintermann Series H3 Total Ankle Replacement has a higher-than-expected risk of device failure, revision surgery, and polyethylene component fractures compared with other ankle replacement systems. (U.S. Food and Drug Administration)

What are the signs that a total ankle replacement is failing?

Common signs include worsening pain, swelling, instability, difficulty walking, inability to bear weight, grinding sensations, and reduced ankle function. (U.S. Food and Drug Administration)

What is revision surgery for an ankle replacement?

Revision surgery is a procedure performed to repair, replace, or remove a failed ankle implant because of complications such as loosening, fracture, infection, or instability.

How often does the Hintermann H3 fail?

FDA-reviewed data found significantly higher revision rates than expected and nearly double the revision risk compared to other ankle replacement devices. Earlier FDA data showed revision or removal rates substantially exceeding those observed during premarket studies. (U.S. Food and Drug Administration)

Can a broken ankle implant cause permanent problems?

Yes. Failed ankle implants may lead to chronic pain, loss of mobility, bone loss, infection, repeated surgeries, and permanent functional limitations.

Should I have my Hintermann H3 implant removed?

Not necessarily. The FDA does not recommend removing a well-functioning implant solely because of the safety communication. Patients should discuss any symptoms or concerns with their orthopedic surgeon. (U.S. Food and Drug Administration)

Hintermann H3 Regulatory History and Potential Preemption Issues

One important question in any medical device lawsuit is how the product reached the market and whether federal law may limit certain state-law claims. The regulatory history of the Hintermann Series H3 Total Ankle Replacement may become a significant issue in future litigation. This is critical because this product will be difficult to challenge due to the law. KBD Attorneys product liability and medical device attorneys have dealt with these issues several times before.

How Did the Hintermann H3 Receive FDA Approval?

Unlike many orthopedic implants that enter the market through the FDA’s less-rigorous 510(k) clearance process, the Hintermann Series H3 Total Ankle Replacement received approval through the FDA’s Premarket Approval (PMA) pathway in 2019.

The PMA process is the FDA’s most stringent review pathway for medical devices. Manufacturers must provide extensive evidence regarding a device’s safety and effectiveness, including clinical studies, engineering data, manufacturing information, and labeling materials.

The FDA approved the Hintermann H3 under PMA number P180009 after reviewing clinical data involving patients with end-stage ankle arthritis. At the time of approval, the FDA concluded that the benefits of the device outweighed its risks when used according to approved labeling.

As a condition of approval, the manufacturer was required to conduct post-approval studies to monitor long-term performance and identify complications that may not have appeared during premarket testing.

Ironically, it was these post-approval studies that eventually led to the FDA’s safety communications warning of higher-than-expected failure rates, increased revision surgeries, and polyethylene bearing fractures.

What Is Federal Preemption?

When a medical device receives PMA approval, manufacturers often argue that federal law preempts—or blocks—certain state-law claims.

The doctrine arises from the federal Medical Device Amendments (MDA) to the Food, Drug, and Cosmetic Act. In the landmark case of Riegel v. Medtronic, Inc., the U.S. Supreme Court held that many state-law claims challenging the safety or effectiveness of a PMA-approved medical device are preempted because they would impose requirements different from or in addition to federal requirements.

As a result, traditional design defect claims against PMA-approved devices often face significant hurdles.

Why Preemption May Not End the Case

Although PMA approval can create substantial defenses, preemption is not absolute.

The Supreme Court recognized in Riegel v. Medtronic, Inc. that claims based on violations of federal requirements may proceed. These are commonly known as “parallel claims.”

Courts have allowed plaintiffs to pursue claims alleging that a manufacturer:

• Failed to comply with FDA-approved manufacturing requirements.
• Failed to report adverse events to the FDA.
• Failed to comply with post-approval study obligations.
• Marketed devices in ways inconsistent with FDA approval.
• Violated specific FDA regulations governing quality systems and reporting.

The FDA’s recent safety communications are noteworthy because they reference post-approval study findings, registry data, adverse event reports, and ongoing monitoring obligations. Those issues frequently become central in litigation involving PMA-approved medical devices.

Could the FDA’s Findings Affect Future Litigation?

Potentially.

According to the FDA, post-market data revealed significantly higher revision rates and polyethylene fracture rates than anticipated during the approval process. The agency also noted that these concerns emerged after broader real-world use of the device.

Future litigation may focus on questions such as:

• When did the manufacturer first become aware of elevated failure rates?
• Were adverse events reported to the FDA in a timely manner?
• Were post-approval study requirements fully satisfied?
• Did labeling and physician warnings adequately reflect emerging risks?
• Were revisions to warnings sought promptly after safety signals emerged?

The answers to those questions could be important because federal law generally does not protect manufacturers who fail to comply with FDA requirements.

What This Means for Patients

The existence of PMA approval does not necessarily mean a patient lacks a legal claim. Rather, PMA-approved device cases often require a detailed examination of FDA records, post-market surveillance data, adverse event reports, recall information, and regulatory compliance history.

For patients who experienced implant failure, revision surgery, polyethylene fracture, or other serious complications following implantation of a Hintermann H3 ankle replacement, the device’s regulatory history may become a critical part of evaluating potential legal claims.

Potential Questions and Answers About How We Got to the FDA

Hintermann H3 Notice

Was the Hintermann H3 approved by the FDA?

Yes. The Hintermann Series H3 Total Ankle Replacement received FDA Premarket Approval (PMA) in 2019, the agency’s most rigorous device review pathway. This does not appear to be a product FDA cleared through the 510(k) process.

What is PMA approval?

Premarket Approval (PMA) is the FDA process used for many high-risk medical devices. Manufacturers must provide scientific evidence demonstrating reasonable assurance of safety and effectiveness before marketing the device.

Does FDA approval prevent lawsuits?

In some states, possible. In others, it is more possible to bring a lawsuit. FDA approval may limit certain claims under the doctrine of federal preemption, but lawsuits may still proceed when plaintiffs allege violations of FDA requirements or other recognized exceptions.

What is a parallel claim in a medical device lawsuit?

A parallel claim alleges that a manufacturer violated federal requirements imposed by the FDA. Courts have held that such claims may survive preemption if properly pleaded and supported by evidence.

Can a PMA-approved medical device still be defective?

Yes. FDA approval does not guarantee that a device will never fail or cause injuries. Post-market surveillance, adverse event reporting, and safety communications exist because risks sometimes emerge only after widespread patient use.

Authoritative Sources

• FDA June 2026 Safety Communication
• FDA February 2024 Safety Communication
• FDA Medical Device Safety Communications

Contact KBD Attorneys

The FDA has stated that it is continuing to review information related to this potentially high-risk device issue and will provide updates as additional information becomes available. (U.S. Food and Drug Administration)

If your child suffered a serious birth injury, hypoxic brain injury, HIE diagnosis, cerebral palsy, or other neurological complications following neonatal resuscitation, KBD Attorneys can help evaluate whether a defective medical device may have played a role.

Contact us confidentially at 855-KBD-LAWS (855-267-3127) or electronically.

This article is for informational purposes only and does not constitute legal advice. It concerns:

• Hintermann Series H3 notice
• Hintermann H3 revision surgery
• H3 total ankle replacement lawsuit
• Hintermann ankle implant failure
• Failed ankle replacement symptoms
• Polyethylene fracture ankle implant
• Total ankle replacement revision
• FDA ankle replacement warning
• DT MedTech ankle replacement
• Hintermann H3 complications